Alzheimer's disease (AD) pathology begins decades before the onset of clinical symptoms. It
is recognized as a clinicobiological entity, being detectable in vivo independently of the …

A correct clinical diagnosis in the early stage of Alzheimer disease is not only of importance
given the current available treatment with acetylcholine esterase inhibitors, but would be the …

Degenerative cognitive disorders, such as Alzheimer disease (AD), exist along a spectrum
from a preclinical stage of individuals without symptoms but with biological predisposition 1 …

Abstract Background Neuroimaging-biomarkers of Mild Cognitive Impairment (MCI) allow an
early diagnosis in preclinical stages of Alzheimer's disease (AD). The goal in this paper was …

Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

In the last decades, progress in neuroimaging techniques and cerebrospinal fluid assays
has enabled the characterization of several Alzheimer's disease (AD) biomarkers. This …

The neuropathological processes eventually leading to Alzheimer's disease (AD) are
thought to start decades before the appearance of clinical symptoms and the clinical …

With the recent advances in treatment of Alzheimer's disease (AD) in the last decade, focus
has shifted increasingly to accurate detection of earliest phase of the illness. This includes …

Few public health problems have captured the attention of the biomedical and lay
communities alike as has Alzheimer Disease (AD). Several questions remain still open in …

Even with the progress that has been made in the past years on our understanding of Alz‐-
heimer's disease (AD) we don't seem to be closer to finding a cure than we were before. AD …